Contact Lenses/Eye Wear News

As the number of myopia cases increases globally, implementing effective therapies to slow the progression and provide optimal vision correction is critical.

Patients with keratoconus are known to have higher rates of depression, anxiety and other psychiatric diagnoses compared with the general population.

Johnson & Johnson Vision announced that the FDA approved a parameter expansion for Acuvue Abiliti Overnight Therapeutic Lenses for Myopia Management from 4 D to 6 D.

SAN DIEGO — Alcon announced plans to introduce a toric design for its Total30 contact lenses in early 2023, according to company executives who spoke during a press conference for the company’s 75th anniversary at Academy 2022.

Health Canada has approved Johnson & Johnson Vision’s Acuvue Abiliti Overnight Therapeutic Lenses for Myopia Management, the company announced in a press release.

SAN DIEGO — Diffusion Optics Technology spectacle lenses were safe and statistically significantly reduced axial length at 3 years in children who began treatment between ages 6 and 10 years, according to a study presented at Academy 2022.

SAN DIEGO — Data from a 7-year clinical study of the MiSight 1-Day myopia control lens indicated that the fastest progressing eyes slowed the most during treatment, as reported at a virtual press conference held during Academy 2022.

More than 90% of children with myopia experienced a decrease in progression with the use of NaturalVue Multifocal contact lenses, according to study results published in Clinical Ophthalmology.

A recent survey estimated that nearly 3,000 practitioners are prescribing and fitting orthokeratology, and that number is expected to climb in the next 2 years, according to new research in Optometry and Vision Science.

LAS VEGAS — CooperVision announced the expansion of its MyDay toric contact lens line to match the range of the Biofinity toric2, as well the addition of MyDay Energys to its product portfolio, during Vision Expo West.